Pharmaceuticals

27 January 2023 by Amy Sandys

In-house

Sandoz appoints global head of IP litigation ahead of Novartis spin-off

Sandoz has announced Kit Carter, previously a senior associate at Pinsent Masons, as its new global head of IP litigation. In her new role, Carter wil ...

29 December 2022 by Mathieu Klos

Germany

ZSP boosts litigation expertise with life sciences partner

Pharmaceutical expert Jens Schiener will join Munich patent attorney firm ZSP Patentanwälte at the beginning of 2023. The firm is thus preparing for t ...

19 December 2022 by Mathieu Klos

Germany

Major spin-off at Boehmert & Boehmert in Munich

Jan Krauss and Nils Schmid are leaving top German firm Boehmert & Boehmert along with three other patent attorneys to set up their own outfit in M ...

16 December 2022 by Mathieu Klos

Germany

MFG hires former Isenbruck patent attorney to strengthen life sciences practice

Sandra Zinner joined the Munich patent attorney firm MFG on 1 December. This is the first time that the firm has strengthened its position in the life ...

6 December 2022 by Mathieu Klos

The Netherlands

Dutch court extends cross-border jurisdiction in Novartis and Pharmathen battle

Pharmathen is still unable to sell its cancer drug Okrodin in many European countries after the Court of Appeal in The Hague largely upheld a prelimin ...

25 November 2022 by Joshua Silverwood

Regeneron successfully defends patent for cholesterol inhibitor at the EPO

Regeneron has successfully repelled an attempt to invalidate its blockbuster patent for cholesterol-inhibiting medication at the EPO Technical Boards ...

18 November 2022 by Joshua Silverwood

Teva and Pinsent Masons invalidate two Novartis patents for Exjade

The High Court of England and Wales has invalidated two Novartis patents following revocation proceedings brought by Teva. The dispute concerns medica ...

JUVE Patent rankings 2022

BioNTech named as IP In-house Team of the Year at JUVE Awards

Last Thursday, at the Frankfurt Opera House, JUVE presented its annual awards for German law firm and In-house teams across 18 different categories. T ...

3 November 2022 by Mathieu Klos

1 November 2022 by Konstanze Richter

Acorda fails in PI proceedings over MS drug Fampyra against Ratiopharm

How important is a provisional opinion of the Federal Patent Court for a preliminary injunction? In the dispute between Acorda and Ratiopharm, the Hig ...

24 October 2022 by Joshua Silverwood

UK

Osborne Clarke strengthens biotech practice with Marks & Clerk hire

The London office of Osborne Clarke is building up its pharmaceutical and biotech practice with the addition of a new partner, Trevor Crosse. He joins ...

11 October 2022 by Konstanze Richter

Biogen fails against multiple generics over MS drug Tecfidera

The Regional Court Düsseldorf and the Judicial Court of Paris have both rejected Biogen's preliminary injunction applications against generic drug man ...

23 September 2022 by Joshua Silverwood

Synthon succeeds with Brinkhof and BarentsKrans in jurisidiction claim against Teva

After overturning a first-instance decision, the Amsterdam Court of Appeal is now claiming jurisdiction to hear a cross-border dispute between Teva an ...

13 September 2022 by Joshua Silverwood

Pharma business

Sandoz spin-off could open door to new litigation against Novartis

Novartis has announced it is to divest its generics division Sandoz. The subsidiary, which runs the business of biosimilars and off-patent drugs, will ...

1 September 2022 by Konstanze Richter

Second medical use

Düsseldorf Regional Court rejects PI in fingolimod case

In the pan-European dispute over fingolimod, Novartis has now suffered a setback in Germany. Düsseldorf Regional Court dismissed the company's applica ...